11 March 2021
LSP is excited to announce BioCapital Europe will be a digital-only event for 2021. Due to the current COVID-19 pandemic, BioCapital will be using best-in-class digital event technology to deliver everything you have come to know from BioCapital from the comfort of your home or office.
BioCapital Europe 2021, organised by LSP (Life Sciences Partners) is delighted to announce its 18th consecutive event, taking place on 11th March 2021 using a best-in-class digital platform. Due to the current state of COVID-19 around the world, BioCapital Europe will be a digital only event, enabling you to access everything BioCapital has to offer from the comfort of your home or office.
BioCaptail Europe 2021, will offer you the opportunity to access all presentations digitally both live and on-demand, as well offering you the same networking opportunities through lading virtual event technology.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe. Attendance is by invitation only. In 2018, the event attracted over 250 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.